What disease is associated with the inability to process mucopolysaccharides?

Hunter Syndrome is indeed the correct response because it is a specific type of mucopolysaccharidosis resulting from the deficiency of an enzyme involved in the breakdown of mucopolysaccharides, which are long chains of sugar molecules that play a crucial role in connective tissue. This condition is part of a group of inherited metabolic disorders and leads to the accumulation of these substances in the body's tissues, causing progressive damage.

Individuals with Hunter Syndrome typically exhibit various symptoms that may include developmental delays, physical disabilities, and characteristic facial features. The condition is X-linked, primarily affecting males, which gives it a distinctive inheritance pattern.

In contrast, the other conditions listed do not involve the processing of mucopolysaccharides. Adrenoleukodystrophy primarily affects the metabolism of certain fats and is associated with adrenal gland function and neurological symptoms. Phenylketonuria (PKU) involves the body's inability to process phenylalanine, an amino acid, leading to cognitive impairments if untreated. Galactosemia is characterized by the inability to metabolize galactose, related to lactose consumption, and does not pertain to mucopolysaccharides either. Understanding the specific enzyme deficiencies and the pathways they affect is crucial for differentiating these conditions.